Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol to Prevent Neonatal Respiratory Morbidity in Elective Cesarean Section
NCT06946914Phase 4Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of misoprostol in respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTN), sponsored by Kafrelsheikh University. Started Jun 2024; status: recruiting.
02
Drugs
misoprostol
03
Conditions
respiratory distress syndrome (RDS)transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on NCT06946914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06946914.